Literature DB >> 10185190

International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.

.   

Abstract

The Food and Drug Administration (FDA) is publishing a guidance entitled "E9 Statistical Principles for Clinical Trials." The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance is intended to provide recommendations to sponsors and scientific experts regarding statistical principles and methodology which, when applied to clinical trials for marketing applications, will facilitate the general acceptance of analyses and conclusions drawn from the trials.

Entities:  

Mesh:

Year:  1998        PMID: 10185190

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  39 in total

Review 1.  Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

Authors:  N Freemantle
Journal:  BMJ       Date:  2001-04-21

2.  A simplified formula for quantification of the probability of deterministic assignments in permuted block randomization.

Authors:  Wenle Zhao; Yanqiu Weng
Journal:  J Stat Plan Inference       Date:  2011-01-01       Impact factor: 1.111

Review 3.  The art and science of risk management: a US research-based industry perspective.

Authors:  Janice K Bush; Wanju S Dai; Gretchen S Dieck; Linda S Hostelley; Thomas Hassall
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Robust extraction of covariate information to improve estimation efficiency in randomized trials.

Authors:  Kelly L Moore; Romain Neugebauer; Thamban Valappil; Mark J Laan
Journal:  Stat Med       Date:  2011-07-12       Impact factor: 2.373

5.  Beyond the intention-to-treat in comparative effectiveness research.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz
Journal:  Clin Trials       Date:  2011-09-23       Impact factor: 2.486

6.  Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists.

Authors:  Mohammad Ali Mansournia; Julian P T Higgins; Jonathan A C Sterne; Miguel A Hernán
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

Review 7.  'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.

Authors:  Andrea Manca; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

8.  GLUMIP 2.0: SAS/IML Software for Planning Internal Pilots.

Authors:  John A Kairalla; Christopher S Coffey; Keith E Muller
Journal:  J Stat Softw       Date:  2008-11-13       Impact factor: 6.440

9.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

10.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.